Immediate Impact

1 from Science/Nature 28 hit
Sub-graph 1 of 14

Citing Papers

CAR-T cell therapy for cancer: current challenges and future directions
2025 Hit
Diabetes-Driven Atherosclerosis: Updated Mechanistic Insights and Novel Therapeutic Strategies
2025 Hit
2 intermediate papers

Works of Benoît De Renzis being referenced

A Phase I-II Study of the Efficacy and Safety of Lenalidomide (LEN) Combined to Azacitidine (AZA) in Higher Risk MDS and AML with Del 5q - a Study By the Groupe Francophone Des Myelodysplasies (GFM)
2015
Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM)
2013

Author Peers

Author Last Decade Papers Cites
Benoît De Renzis 117 89 67 30 14 15 138
Lourdes Hermosín 142 91 81 30 16 11 220
M. F. McMullin 147 119 105 45 22 17 197
Anne-Marie Watson 109 35 48 44 13 12 137
Barbara Grohmann-Izay 52 80 37 57 15 11 115
Shouryadeep Srivastava 67 55 38 27 9 16 106
Eveline S. de Bont 72 47 36 36 28 16 117
Atanas Radinoff 152 107 60 11 14 13 181
Houda Hamdi‐Rozé 72 68 107 8 20 14 227
Craig A. Kovitz 87 74 20 44 7 13 130
S. Schnittger 118 42 97 11 30 13 156

All Works

Loading papers...

Rankless by CCL
2026